Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1991 Apr;66(4):517–520. doi: 10.1136/adc.66.4.517

Gonadal function after allogenic bone marrow transplantation for thalassaemia.

V De Sanctis 1, M Galimberti 1, G Lucarelli 1, P Polchi 1, L Ruggiero 1, C Vullo 1
PMCID: PMC1792971  PMID: 1903244

Abstract

Thirty prepubertal patients with thalassaemia major (15 boys and 15 girls) aged from 9.3 to 17.2 years (mean 12.9) who had successfully undergone allogenic bone marrow transplantation were studied. Before the transplant all patients were given short courses of high doses of busulphan (total dose 14 mg/kg) followed by cyclophosphamide (total dose 200 mg/kg). Pituitary gonadal function was assessed between 0.7 and 5.1 years (mean 2.3) after bone marrow transplantation. Increased gonadotrophin concentrations indicating gonadal damage were found in 80% of the girls, probably as a result of the chemotherapy. In all the prepubertal boys the basal follicle stimulating hormone and luteinising hormone concentrations were normal. Most of the boys had reduced gonadotrophin and testosterone responses after gonadotrophin releasing hormone and human chorionic gonadotrophin tests. This could have been the result of iron overload but the effect of cytotoxic agents cannot be excluded. These findings emphasise the need for vigilant long term follow up of thalassaemic patients treated with cytotoxic chemotherapy for bone marrow transplantation so that those requiring hormone replacement can be identified and treated.

Full text

PDF
517

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Chalabi H. A. Effect of cyclosporin A on the morphology and function of the ovary and fertility in the rabbit. Int J Fertil. 1984;29(4):218–223. [PubMed] [Google Scholar]
  2. Anoussakis C., Alexiou D., Abatzis D., Bechrakis G. Endocrinological investigation of pituitary conadal axis in thalassemia major. Acta Paediatr Scand. 1977 Jan;66(1):49–51. doi: 10.1111/j.1651-2227.1977.tb07806.x. [DOI] [PubMed] [Google Scholar]
  3. Beck W., Schwarz S., Heidemann P. H., Jentsch E., Stubbe P., König A. Hypergonadotropic hypogonadism, SHBG deficiency and hyperprolactinaemia: a transient phenomenon during induction chemotherapy in leukemic children. Eur J Pediatr. 1982 May;138(3):216–220. doi: 10.1007/BF00441205. [DOI] [PubMed] [Google Scholar]
  4. Benker G., Schäfer U., Hermanns U., Mahmoud M. K., Olbricht T., Schulte H. M., Windeck R., Reinwein D. Allogenic bone marrow transplantation in adults: endocrine sequelae after 1-6 years. Acta Endocrinol (Copenh) 1989 Jan;120(1):37–42. doi: 10.1530/acta.0.1200037. [DOI] [PubMed] [Google Scholar]
  5. Borgna-Pignatti C., De Stefano P., Zonta L., Vullo C., De Sanctis V., Melevendi C., Naselli A., Masera G., Terzoli S., Gabutti V. Growth and sexual maturation in thalassemia major. J Pediatr. 1985 Jan;106(1):150–155. doi: 10.1016/s0022-3476(85)80488-1. [DOI] [PubMed] [Google Scholar]
  6. Chapman R. M. Gonadal injury resulting from chemotherapy. Am J Ind Med. 1983;4(1-2):149–161. [PubMed] [Google Scholar]
  7. Conte F. A., Grumbach M. M., Kaplan S. L., Reiter E. O. Correlation of luteinizing hormone-releasing factor-induced luteinizing hormone and follicle-stimulating hormone release from infancy to 19 years with the changing pattern of gonadotropin secretion in agonadal patients: relation to the restraint of puberty. J Clin Endocrinol Metab. 1980 Jan;50(1):163–168. doi: 10.1210/jcem-50-1-163. [DOI] [PubMed] [Google Scholar]
  8. Costin G., Kogut M. D., Hyman C. B., Ortega J. A. Endocrine abnormalities in thalassemia major. Am J Dis Child. 1979 May;133(5):497–502. doi: 10.1001/archpedi.1979.02130050041009. [DOI] [PubMed] [Google Scholar]
  9. De Sanctis V., Atti G., Lucci M., Vullo C., Bagni B., Candini G., Cavallini A. R., Sabato A. Endocrine assessment of hypogonadism in patients affected by thalassaemia major. Ric Clin Lab. 1980 Oct-Dec;10(4):663–671. doi: 10.1007/BF02906703. [DOI] [PubMed] [Google Scholar]
  10. De Sanctis V., Vullo C., Katz M., Wonke B., Hoffbrand A. V., Bagni B. Hypothalamic-pituitary-gonadal axis in thalassemic patients with secondary amenorrhea. Obstet Gynecol. 1988 Oct;72(4):643–647. [PubMed] [Google Scholar]
  11. De Sanctis V., Vullo C., Katz M., Wonke B., Nannetti C., Bagni B. Induction of spermatogenesis in thalassaemia. Fertil Steril. 1988 Dec;50(6):969–975. doi: 10.1016/s0015-0282(16)60382-5. [DOI] [PubMed] [Google Scholar]
  12. De Sanctis V., Vullo C., Katz M., Wonke B., Tanas R., Bagni B. Gonadal function in patients with beta thalassaemia major. J Clin Pathol. 1988 Feb;41(2):133–137. doi: 10.1136/jcp.41.2.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Glode L. M., Robinson J., Gould S. F. Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotropin-releasing hormone. Lancet. 1981 May 23;1(8230):1132–1134. doi: 10.1016/s0140-6736(81)92301-1. [DOI] [PubMed] [Google Scholar]
  14. HELLER R. H., JONES H. W., Jr PRODUCTION OF OVARIAN DYSGENESIS IN THE RAT AND HUMAN BY BUSULPHAN. Am J Obstet Gynecol. 1964 Jun 1;89:414–420. doi: 10.1016/0002-9378(64)90704-5. [DOI] [PubMed] [Google Scholar]
  15. Landau H., Spitz I. M., Cividalli G., Rachmilewitz E. A. Gonadotrophin, thyrotrophin and prolactin reserve in beta thalassaemia. Clin Endocrinol (Oxf) 1978 Aug;9(2):163–173. doi: 10.1111/j.1365-2265.1978.tb02194.x. [DOI] [PubMed] [Google Scholar]
  16. Livesey E. A., Brook C. G. Gonadal dysfunction after treatment of intracranial tumours. Arch Dis Child. 1988 May;63(5):495–500. doi: 10.1136/adc.63.5.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Quigley C., Cowell C., Jimenez M., Burger H., Kirk J., Bergin M., Stevens M., Simpson J., Silink M. Normal or early development of puberty despite gonadal damage in children treated for acute lymphoblastic leukemia. N Engl J Med. 1989 Jul 20;321(3):143–151. doi: 10.1056/NEJM198907203210303. [DOI] [PubMed] [Google Scholar]
  18. Salbenblatt J. A., Bender B. G., Puck M. H., Robinson A., Faiman C., Winter J. S. Pituitary-gonadal function in Klinefelter syndrome before and during puberty. Pediatr Res. 1985 Jan;19(1):82–86. doi: 10.1203/00006450-198501000-00022. [DOI] [PubMed] [Google Scholar]
  19. Sanders J. E., Buckner C. D., Amos D., Levy W., Appelbaum F. R., Doney K., Storb R., Sullivan K. M., Witherspoon R. P., Thomas E. D. Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol. 1988 May;6(5):813–818. doi: 10.1200/JCO.1988.6.5.813. [DOI] [PubMed] [Google Scholar]
  20. Sanders J. E., Buckner C. D., Leonard J. M., Sullivan K. M., Witherspoon R. P., Deeg H. J., Storb R., Thomas E. D. Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation. Transplantation. 1983 Sep;36(3):252–255. doi: 10.1097/00007890-198309000-00005. [DOI] [PubMed] [Google Scholar]
  21. Sanders J. E., Buckner C. D., Sullivan K. M., Doney K., Appelbaum F., Witherspoon R., Storb R., Thomas E. D. Growth and development in children after bone marrow transplantation. Horm Res. 1988;30(2-3):92–97. doi: 10.1159/000181036. [DOI] [PubMed] [Google Scholar]
  22. Sanders J. E., Pritchard S., Mahoney P., Amos D., Buckner C. D., Witherspoon R. P., Deeg H. J., Doney K. C., Sullivan K. M., Appelbaum F. R. Growth and development following marrow transplantation for leukemia. Blood. 1986 Nov;68(5):1129–1135. [PubMed] [Google Scholar]
  23. Santos G. W. Immunosuppression for clinical marrow transplantation. Semin Hematol. 1974 Jul;11(3):341–351. [PubMed] [Google Scholar]
  24. Sklar C. A., Kim T. H., Williamson J. F., Ramsay N. K. Ovarian function after successful bone marrow transplantation in postmenarcheal females. Med Pediatr Oncol. 1983;11(5):361–364. doi: 10.1002/mpo.2950110514. [DOI] [PubMed] [Google Scholar]
  25. Wang C., Ng R. P., Chan T. K., Todd D. Effect of combination chemotherapy on pituitary-gonadal function in patients with lymphoma and leukemia. Cancer. 1980 Apr 15;45(8):2030–2037. doi: 10.1002/1097-0142(19800415)45:8<2030::aid-cncr2820450807>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  26. Zaino E. C., Kuo B., Roginsky M. S. Growth retardation in thalassemia major. Ann N Y Acad Sci. 1969 Nov 20;165(1):394–399. doi: 10.1111/j.1749-6632.1969.tb27809.x. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES